A study for a 51 year old man who takes Meloxicam, Androgel, Cymbalta, Morphine, Abilify - from FDA reports


Summary

825 males aged 51 (±5) who take the same drugs are studied. This is a personalized study for a 51 year old male patient who has Low Testosterone, Radiculitis, Major Depression. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Apr, 30, 2017

825 males aged 51 (±5) who take Meloxicam, Androgel, Cymbalta, Morphine, Abilify are studied.


Number of reports submitted per year:

Meloxicam, Androgel, Cymbalta, Morphine, Abilify for a 51-year old man.

Information of the patient in this study:

  • Age: 51
  • Gender: male
  • Conditions: Low Testosterone, Radiculitis, Major Depression
  • Drugs taken:
    • Meloxicam (meloxicam)
    • Androgel (testosterone)
    • Cymbalta (duloxetine hydrochloride)
    • Morphine (morphine sulfate)
    • Abilify (aripiprazole)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • back pain
  • nausea
  • gastrointestinal perforation
  • weakness
  • feeling abnormal
  • pain in extremity
  • heart attack
  • suicide attempt
  • coronary heart disease
  • high blood pressure
1 - 6 months:
  • stroke
  • nausea and vomiting
  • erection problems
  • hypoglycemia
  • skin candida
  • nausea
  • high blood cholesterol
  • diabetic neuropathy
  • type 2 diabetes
  • weight increased
6 - 12 months:
  • deep venous thrombosis
  • acute myocardial infarction
  • erection problems
  • heart attack
  • pulmonary embolism
  • coronary heart disease
  • dental caries
  • drug abuse and dependence
  • constipation
  • thrombosis
1 - 2 years:
  • sleep apnea syndrome
  • type 2 diabetes
  • heart attack
  • weight loss
  • acute myocardial infarction
  • nausea and vomiting
  • rhabdomyolysis
  • stroke
  • suicide attempt
  • diabetic neuropathy
2 - 5 years:
  • acute myocardial infarction
  • stroke
  • coronary heart disease
  • deep venous thrombosis
  • pulmonary embolism
  • heart attack
  • cardiac failure congestive
  • weight increased
  • suicidal ideation
  • erection problems
5 - 10 years:
  • acute myocardial infarction
  • stroke
  • chest pain
  • emotional distress
  • transient ischaemic attack
  • ischaemic cardiomyopathy
  • cardiac failure congestive
  • stress and anxiety
  • quality of life decreased
  • panic disorder
10+ years:
  • coronary artery occlusion
  • white blood cell count increased
  • heart attack
not specified:
  • pain
  • fatigue
  • nausea
  • stress and anxiety
  • drug ineffective
  • depression
  • weakness
  • nausea and vomiting
  • pneumonia
  • diarrhea

Top conditions involved for these people *:

  • Depression (184 people, 22.30%)
  • Pain (182 people, 22.06%)
  • High Blood Pressure (85 people, 10.30%)
  • Blood Testosterone Decreased (79 people, 9.58%)
  • Stress And Anxiety (67 people, 8.12%)

Top co-used drugs for these people *:

  • Lyrica (111 people, 13.45%)
  • Neurontin (92 people, 11.15%)
  • Ambien (73 people, 8.85%)
  • Nexium (72 people, 8.73%)
  • Seroquel (70 people, 8.48%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Morphine, Cymbalta, Major depression, Abilify, Androgel, Low testosterone, Meloxicam, Radiculitis

You may be interested in these reviews

More reviews for: Morphine, Cymbalta, Major depression, Abilify, Androgel, Low testosterone, Meloxicam, Radiculitis